Trans-thoracic echocardiography (TTE) has traditionally been the bedrock for identification, quantification and monitoring of valvular disease (1, 2). Obtaining the minimum data set provides valuable information about valvular anatomy, presence and severity of pathology and subsequent impact on cardiac chambers and great vessels (3).
However, there are certain instances where further information is required, whether due to sub-optimal image quality, eccentric disease or conflicting data. This editorial aims to provide a brief overview into the value of some of the available imaging modalities which is summarised in Figure 1.
